TY  - RPRT
TI  - Safety, pharmacokinetics and pharmacodynamics of TQC3721, an innovative, dual PDE3 and PDE4 inhibitor, in healthy subjects and patients with chronic obstructive pulmonary disease: Randomised, double-blind, placebo-controlled phase I and IIa clinical trials.
AU  - Lixiu He
AU  - Ling Yang
AU  - Weiguo Li
AU  - Yang Yu
AU  - Ding Yu
AU  - Hui Chen
AU  - Songze Wu
AU  - Zhu Luo
PY  - 2026
DO  - 10.1111/bph.70588
UR  - https://pubmed.ncbi.nlm.nih.gov/42449486/
ID  - 42449486
ER  -